BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33810594)

  • 1. Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect.
    Lazaridis A; Gavriilaki E; Douma S; Gkaliagkousi E
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33810594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.
    McCarthy CG; Goulopoulou S; Wenceslau CF; Spitler K; Matsumoto T; Webb RC
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(2):H184-96. PubMed ID: 24163075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors and hypertension.
    Singh MV; Abboud FM
    Am J Physiol Regul Integr Comp Physiol; 2014 Sep; 307(5):R501-4. PubMed ID: 24920728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptor activation, vascular endothelial function, and hypertensive disorders of pregnancy.
    Balasubbramanian D; Gelston CAL; Mitchell BM; Chatterjee P
    Pharmacol Res; 2017 Jul; 121():14-21. PubMed ID: 28419848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation, immunity, and hypertensive end-organ damage.
    McMaster WG; Kirabo A; Madhur MS; Harrison DG
    Circ Res; 2015 Mar; 116(6):1022-33. PubMed ID: 25767287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury.
    Lehnardt S
    Glia; 2010 Feb; 58(3):253-63. PubMed ID: 19705460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune system in hypertension.
    Trott DW; Harrison DG
    Adv Physiol Educ; 2014 Mar; 38(1):20-4. PubMed ID: 24585465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immune system and hypertension.
    Singh MV; Chapleau MW; Harwani SC; Abboud FM
    Immunol Res; 2014 Aug; 59(1-3):243-53. PubMed ID: 24847766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
    Xu D; Liu H; Komai-Koma M
    Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleic Acid-Sensing Toll-Like Receptors Play a Dominant Role in Innate Immune Recognition of Pneumococci.
    Famà A; Midiri A; Mancuso G; Biondo C; Lentini G; Galbo R; Giardina MM; De Gaetano GV; Romeo L; Teti G; Beninati C
    mBio; 2020 Mar; 11(2):. PubMed ID: 32209688
    [No Abstract]   [Full Text] [Related]  

  • 11. Toll-like Receptors in the Vascular System: Sensing the Dangers Within.
    Goulopoulou S; McCarthy CG; Webb RC
    Pharmacol Rev; 2016 Jan; 68(1):142-67. PubMed ID: 26721702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TRIPS (Toll-like receptors in immuno-inflammatory pathogenesis) Hypothesis: a novel postulate to understand schizophrenia.
    Venkatasubramanian G; Debnath M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():301-11. PubMed ID: 23587629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between Angiotensin II, TLR4 and hypertension.
    Biancardi VC; Bomfim GF; Reis WL; Al-Gassimi S; Nunes KP
    Pharmacol Res; 2017 Jun; 120():88-96. PubMed ID: 28330785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The innate immune system, toll-like receptors and dermal wound healing: A review.
    Portou MJ; Baker D; Abraham D; Tsui J
    Vascul Pharmacol; 2015 Aug; 71():31-6. PubMed ID: 25869514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenetic Mechanisms of Hypertension-Brain-Induced Complications: Focus on Molecular Mediators.
    Di Chiara T; Del Cuore A; Daidone M; Scaglione S; Norrito RL; Puleo MG; Scaglione R; Pinto A; Tuttolomondo A
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime?
    Barrows IR; Ramezani A; Raj DS
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):122-130. PubMed ID: 31023446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
    Lin Q; Li M; Fang D; Fang J; Su SB
    Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking oxidative stress to inflammation: Toll-like receptors.
    Gill R; Tsung A; Billiar T
    Free Radic Biol Med; 2010 May; 48(9):1121-32. PubMed ID: 20083193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of Toll-like receptor signaling pathways in the induction and progression of autoimmune diseases.
    Li M; Zhou Y; Feng G; Su SB
    Curr Mol Med; 2009 Apr; 9(3):365-74. PubMed ID: 19355917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial cell Toll-like receptor pathways in sepsis.
    Khakpour S; Wilhelmsen K; Hellman J
    Innate Immun; 2015 Nov; 21(8):827-46. PubMed ID: 26403174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.